SEC Form 4 · accession 0001209191-18-033564
ChronoScale Holdings Corp · CHRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Sherman
Director
Period of report
May 23, 2018
Accepted (ET)
May 25, 2018 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001549084
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 23, 2018 | P | 100,000 | $1.4999 | A | 300,825 | D | |
| Common StockF3 | May 23, 2018 | P | 100,000 | $1.5156 | A | 400,825 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.53, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- F2This number reflects the 1-for-7 reverse stock split that occurred on May 4, 2016.
- F3The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.53, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.